The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota, Am. J. Ophthalmol, vol.120, pp.511-517, 1995. ,
Epidemiology and prevention of Graves' ophthalmopathy, Thyroid, vol.12, pp.855-860, 2002. ,
Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial, Clin Endocrinol (Oxf.), vol.63, pp.323-328, 2005. ,
Moisture chamber for management of corneal ulcer due to Graves' ophthalmopathy, Thyroid, vol.10, pp.1123-1124, 2000. ,
Thyroid associated ophthalmopathy: botulinum toxin A in the treatment of upper eyelid retraction-a pilot study, Acta Ophthalmol Scand, vol.79, pp.585-588, 2001. ,
Amniotic membrane transplantation for reconstruction of corneal ulcer in graves ophthalmopathy, Cornea, vol.23, pp.524-526, 2004. ,
Dysthyroid optic neuropathy. Clinical profile and rationale for management, Arch Ophthalmol, vol.96, pp.1199-1209, 1978. ,
Clinical profile and visual outcomes after treatment in patients with dysthyroid optic neuropathy, Korean J Ophthalmol, vol.26, pp.73-79, 2012. ,
Methylprednisolone pulse therapy for patients with dysthyroid optic neuropathy, Orbit Amst Neth, vol.20, pp.275-280, 2001. ,
Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey, Br J Ophthalmol, vol.91, pp.455-458, 2007. ,
PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from, Br J Ophthalmol, vol.99, pp.1531-1535, 2000. ,
Graves' Orbitopathy: A Multidisciplinary Approach, pp.1-27, 2007. ,
Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy, Thyroid, vol.24, pp.897-905, 2014. ,
Tocilizumab as first treatment option in optic neuropathy secondary to Graves' orbitopathy, Orbit Amst Neth, vol.8, pp.1-4, 2018. ,
European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy, Eur. Thyroid J, vol.5, pp.9-26, 2016. ,
Methylprednisolone pulse therapy in severe dysthyroid optic neuropathy, Ophthalmology, vol.96, pp.1048-1053, 1989. ,
Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis, J Clin Endocrinol Metab, vol.94, pp.2708-2716, 2009. ,
Clinical review: Intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity, J Clin Endocrinol Metab, vol.96, pp.320-332, 2011. ,
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study, Eur J Endocrinol, vol.172, pp.269-276, 2015. ,
Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy, Endokrynol Pol, vol.67, pp.166-173, 2016. ,